Y-Intercept (HK)’s Fulgent Genetics FLGT Stock Holding History

Y-Intercept (HK)’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-67,697	Closed	-$1.08M	–	1861
2026 Q1	$1.08M	Buy	+67,697	New	+$1.47M	0.02%	999
2025 Q2	–	Sell	-62,129	Closed	-$1.05M	–	1744
2025 Q1	$1.05M	Buy	+62,129	New	+$1.06M	0.07%	390
2022 Q1	–	Sell	-3,069	Closed	-$309K	–	793
2021 Q4	$309K	Buy	+3,069	New	+$270K	0.07%	392

Other funds holding FLGT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s FLGT Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 67,697 shares — an estimated $1.08M sold.

Y-Intercept (HK) first reported a position in FLGT in Q4 2021 and held it in 3 quarters. The position peaked at $1.08M in Q1 2026. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

Y-Intercept (HK) reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 67,697 Fulgent Genetics shares in Q2 2026, an estimated $1.08M.
Y-Intercept (HK) first reported a position in Fulgent Genetics in Q4 2021 and held it in 3 quarters.
Y-Intercept (HK)'s Fulgent Genetics position peaked at $1.08M in Q1 2026.
142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.